In addition, patients with NAFLD differed from early NAFLD only in higher ALT and AST activity but had the same GGTP values, anthropometric measurements, lipid profile and glucose concentration. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.